1. Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinoma
   Matteo Santoni et al, 2014, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
2. Aurora-A promotes chemoresistance in hepatocelluar carcinoma by targeting NF-kappaB/microRNA-21/PTEN signaling pathway
   Kai Zhang et al, 2014, Oncotarget CrossRef
3. In vitro evaluation of Aurora kinase inhibitor—VX680—in formulation of PLA-TPGS nanoparticles
   Thi Thuy Duong Le et al, 2016, Advances in Natural Sciences: Nanoscience and Nanotechnology CrossRef
4. mTOR Pathway in Renal Cell Carcinoma
   Matteo Santoni et al, 2016, Molecules to Medicine with mTOR CrossRef
5. VX680 suppresses the growth of HepG2 cells and enhances the chemosensitivity to cisplatin
   RUCHENG YAO et al, 2014, Oncology Letters CrossRef
6. Silencing Aurora A leads to re-sensitization of breast cancer cells to Taxol through downregulation of SRC-mediated ERK and mTOR pathways
   Yan Li et al, 2017, Oncology Reports CrossRef
7. Identification and characterization of deschloro-chlorothricin obtained from a large natural product library targeting aurora A kinase in multiple myeloma
   Nadire Özenver et al, 2021, Investigational New Drugs CrossRef